- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06706531
Additional Effects of Dry Needling With Conventional Physical Therapy Versus Conventional Physical Therapy in Plantar Fasciitis: a Randomized Control Trial
November 22, 2024 updated by: Foundation University Islamabad
This study is a randomized controlled trial and the purpose of this study is to determine the effects of dry needling with conventional physical therapy versus conventional physical therapy on gait parameters in plantar fasciitis: a randomized control trial.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to determine the effects of dry needling with conventional physical therapy versus conventional physical therapy on gait parameters in plantar fasciitis Outcomes variables of Pain , Ankle ROM, gait parameters and activities of daily living in adults (age : 40-60 years ) will be determined using:
- Numeric pain rating scale
- Goniometer
- 30 meter walk test
- foot and ankle ability measure FAAM Data will be before and after the intervention protocol for each participant. Data collection procedure: Participants of interest would be approached and explained about the research. Informed written consent will be taken. Pre and post intervention scores will be recorded.
Study Type
Interventional
Enrollment (Estimated)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Areeba Michelle, MS-MSKPT*
- Phone Number: 0334-8546616
- Email: aribaa.michelle@gmail.com
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 46000
- Recruiting
- Foundation University College of Physical Therapy
-
Contact:
- Qurat ul Ain Saeed, MS-OMPT,PHD*
- Phone Number: 03315562889
- Email: quratulain.saeed@fui.edu.pk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion criteria:
- Age 40-60 years
- Both genders
- Plantar heel pain for longer than 3 months
- Pain score at least or less than 8 on the numeric pain (NPRS)
- Clinical diagnosis of unilateral PF in accordance with the clinical practice guidelines from the Orthopaedic Section of the American Physical Therapy Association APTA:
- Plantar medial heel pain: most noticeable with initial steps after a period of inactivity but also worse following prolonged weight bearing
- Heel pain precipitated by a recent increase in weight bearing activity
- Pain with palpation of the proximal insertion of the plantar fascia
- Positive windlass test
- Negative tarsal tunnel tests
- Limited active and passive talocrural joint dorsiflexion range of motion
- Abnormal foot posture index score
- High body mass index in nonathletic individuals
Exclusion criteria:
- Positive ankle drawer tests
- Pregnant womwn, mental illness, immune suppressed patients, thrombocytopenia, anti-coagulant therapy patients and post-mastectomy
- Congenital abnormalities of foot
- A history of surgery to the ankle, foot or lower leg
- Other causes of heel pain (including tarsal tunnel syndrome, calcaneal fracture, ankle or foot instability, arthritis of the foot or ankle, rheumatoid arthritis, spondyloarthropathy, gout,peripheral neuropathy )
- Presented with 2 or more positive neurologic signs consistent with nerve root compression
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard treatment + Sham Dry needling
Participants will receive standard treatment of plantar facitis along with sham dry needling
|
All participants received up to six treatment sessions at a frequency of twice per week over a 3-week period i.e. ultrasound (0.5 W/cm² of 3 MHz for 5 minutes over plantar aspect of foot), stretching exercises and strengthening exercises.
The exercise pro
The sham dry needling group will also receive 6 sessions of sham dry needling on soleus, quadratus plantae, flexor digitorum brevis, and abductor halluces muscles for 5 minutes.Sterilized disposable stainless steel acupuncture needles of 0.25mm x 30mm will be used with depth of 20-55mm.The plantar and medial surface of the foot and ankle will be cleaned with alcohol.
The sham dry needling will be performed for 5 minutes.
|
|
Experimental: Standard treatment + Dry needling
Participants will receive standard treatment of plantar facitis along with dry needling
|
All participants received up to six treatment sessions at a frequency of twice per week over a 3-week period i.e. ultrasound (0.5 W/cm² of 3 MHz for 5 minutes over plantar aspect of foot), stretching exercises and strengthening exercises.
The exercise pro
The dry needling group will receive 6 sessions of dry needling using a standardized trigger point protocol on soleus, quadratus plantae, flexor digitorum brevis, and abductor halluces muscles for 5 minutes.
Sterilized disposable stainless steel acupuncture needles of 0.25mm x 30mm will be used with depth of 20-55mm.
The calf, plantar and medial surface of the foot and ankle will be cleaned with alcohol.
Following insertion, needles will be manipulated bi-directionally to elicit a sensation of aching, tingling, deep pressure, heaviness or warmth.
The needles will then left in situ for 5 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity
Time Frame: 3 weeks
|
Pain will be measured on Numerical Pain rating scale.
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable").
|
3 weeks
|
|
The Foot and Ankle Ability Measure (FAAM)
Time Frame: 3 weeks
|
It is a self-report outcome instrument developed to assess physical function for individuals with foot and ankle related impairments .The response to each item on the ADL subscale is scored from 4 to 0, with 4 being 'no difficulty' and 0 being 'unable to do'
|
3 weeks
|
|
Gait speed:
Time Frame: 3 weeks
|
Gait speed = Distance (m) / time (s)
|
3 weeks
|
|
Cadence
Time Frame: 3 weeks
|
Cadence (steps/min) = steps counted x 60 / time (s)
|
3 weeks
|
|
Cycle length
Time Frame: 3 weeks
|
Cycle time (s) = time (s) x 2/steps counted
|
3 weeks
|
|
Stride length
Time Frame: 3 weeks
|
SL (m) = speed (m/s) x cycle time (s)
|
3 weeks
|
|
Range of motion
Time Frame: 3 weeks
|
Ankle range will be measured with goniometer
|
3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2024
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
November 22, 2024
First Submitted That Met QC Criteria
November 22, 2024
First Posted (Estimated)
November 26, 2024
Study Record Updates
Last Update Posted (Estimated)
November 26, 2024
Last Update Submitted That Met QC Criteria
November 22, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FUI/CTR/2024/53
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Plantar Fascitis
-
Riphah International UniversityRecruiting
-
Sierra Varona SLUniversidad Europea de MadridNot yet recruitingPlantar Fascitis | Fasciitis | Chronic Plantar Fasciitis
-
Universidad Miguel Hernandez de ElcheFundación para el Fomento de la Investigación Sanitaria y Biomédica de la...Not yet recruitingPlantar FascitisSpain
-
Sultan Qaboos UniversityRecruitingPlantar FascitisOman
-
Prisma Health-MidlandsHewlett-Packard (HP)Active, not recruiting
-
Mike O'Callaghan Military HospitalCompleted
-
Talita Cumi Ltd.Aetrex Worldwide IncCompleted
-
Cardiff and Vale University Health BoardCompletedPlantar FascitisUnited Kingdom
-
brett rasmussenCompleted
-
Landstuhl Regional Medical CenterCompleted
Clinical Trials on Standard treatment
-
Guangdong Provincial People's HospitalRecruitingSensorineural Hearing Loss | Sudden Hearing LossChina
-
Paul CrawfordCompleted
-
Hospital Clinic of BarcelonaUnknown
-
Hospices Civils de LyonTerminatedAnal IncontinenceFrance
-
BaroPace Inc.JSS Medical Research Inc.CompletedHypertension | Heart Failure With Preserved Ejection Fraction (HFpEF)India
-
The University of Hong KongNot yet recruitingStroke | Small Vessel Cerebrovascular Disease
-
Istituto Ortopedico RizzoliRecruiting
-
University of Nove de JulhoRecruiting
-
Yale UniversityNational Institutes of Health (NIH)Completed